Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

NCT06377566

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: University of Miami Miami, Florida, United States

Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States

View Trial Details

Recruiting

Pilot Imaging Study of Leukemia

NCT03633955

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Ambiguous Lineage Leukemia or Lymphoma, +16 more
Locations: Children's National Health System Washington D.C., District of Columbia, United States

Emory University Atlanta, Georgia, United States

University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States

View Trial Details

Recruiting

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

NCT07548697

Conditions: B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +14 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients

NCT06263491

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Childhood Cancer Survivors' Affective Response to Exercise

NCT05763290

Conditions: ALL, Childhood, Acute Lymphoblastic Leukemia, Hematologic Diseases, +10 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

NCT06074666

Conditions: Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Roswell Park Comprehensive Cancer Center Buffalo, New York, United States

View Trial Details

Recruiting

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

NCT07214324

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Istituto Ortopedico Rizzoli IRCCS Bologna, Italy

UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco" Catania, Italy

UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone" Palermo, Italy

S.C Ematologia - Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy

View Trial Details

Recruiting

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

NCT07097363

Conditions: B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

NCT02333604

Conditions: Adnexal Diseases, Blood Protein Disorders, Bone Marrow Diseases, +83 more
Locations: Cancer Support Community Research & Training Institute Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia

NCT06816134

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Conditioning Therapy, +14 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions